Clinical Trial Update: A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk [Phase 2]

View source ↗

Summary

A prospective Phase II study evaluating individualized neoadjuvant chemoradiotherapy for rectal cancer based on recurrence risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Jing Jin, M.D. | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN